MDXG MIMEDX GROUP, INC.
Company Analysis
Latest News
MiMedx Merger with Sanara MedTech Delayed by FTC's Second Antitrust Request
MiMedx Group, Inc. announced that it and Sanara MedTech Inc. have received a request for additional information (a "Second Request") from the Federal Trade...
🔴 MiMedx Group is trading 6.4% down today following earnings miss and $350M Sanara acquisition
MiMedx Group is trading 6.4% down at $4.00 as investors digest a 35% revenue decline and the company's $350 million acquisition of Sanara MedTech. • The stock...
🔴 MiMedx Group is trading 6.3% down today after Q2 earnings and $350M Sanara MedTech acquisition announcement
MiMedx Group is trading at $4.00 (6.3% down) in after-hours trading following its July 29 earnings release and the announcement of a $350 million deal to...
🔴 MiMedx Group is trading 6.7% down today following Sanara acquisition and Medicare reimbursement headwinds
MiMedx Group is trading at $4.05 (6.7% down) as investors digest its second-quarter earnings and the announced acquisition of Sanara MedTech. • The company...
🔴 MiMedx Group is trading 10.2% down today on revenue decline and Sanara MedTech acquisition
MiMedx Group is trading 10.2% down at $3.80 in pre-market following a sharp year-over-year revenue decline and the announcement of a $350 million definitive...
MiMedx's Wound Care Business Is Cratering and It Just Bet $350 Million on an Acquisition — Is This a Lifeline or a Gamble?
Shares of MiMedx Group tumbled 10.9% to $3.77 in after-hours trading on July 29 after the regenerative-medicine company paired a bruising second quarter with a...
🔴 MiMedx Group is trading 10.9% down today on weak Q2 sales and Sanara MedTech acquisition
MiMedx Group is trading 10.9% down at $3.77 in after-hours trading after reporting a 35% year-over-year decline in net sales and announcing a $350 million deal...
MiMedx's second quarter revenue beats on 15% surgical growth as it announces plan to acquire Sanara MedTech.
MiMedx reported second quarter net sales of $64.4 million, a 35% decrease from the prior year, and an adjusted loss per share of $0.05. The results were driven...
MiMedx to Acquire Sanara MedTech in Cash and Stock Transaction
MiMedx Group, Inc. (MDXG) announced it has entered into a definitive merger agreement to acquire Sanara MedTech Inc. Under the terms of the agreement, Sanara...
🔴 MiMedx Group is trading 6.1% down today ahead of Q2 earnings
MiMedx Group is trading 6.1% down at $4.00 ahead of its Q2 2026 earnings report scheduled for July 29, 2026. • Investors are focused on the recovery of the...
MiMedx Group Inc Q2 2026 Earnings Preview: What Analysts Expect on July 29, 2026
Consensus estimates for Q2 2026 place revenue at $63.46 million with an expected adjusted loss of $0.03 per share, while the stock currently trades near $4.20...